Upstream Bio (UPB) Total Liabilities (2023 - 2026)

Upstream Bio's Total Liabilities history runs 4 years deep, the most recent figure standing at $14.1 million for Q1 2026.

• In Q1 2026, Total Liabilities rose 33.15% year-over-year to $14.1 million; the TTM figure through Mar 2026 stood at $14.1 million (up 33.15% YoY), while the FY2025 annual figure was $14.0 million, up 17.98% from the prior year.
• Total Liabilities was $14.1 million for Q1 2026 at Upstream Bio, roughly flat from $14.0 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $146.6 million in Q2 2024 to a low of $9.4 million in Q4 2023.
• Historically, Total Liabilities has averaged $44.4 million across 4 years, with a median of $12.6 million in 2025.
• The sharpest annual moves came in 2025 and 2026: Total Liabilities slumped 92.09% in 2025, then jumped 33.15% in 2026.
• A 4-year view of Total Liabilities shows it stood at $9.4 million in 2023, then rose by 26.39% to $11.9 million in 2024, then rose by 17.98% to $14.0 million in 2025, then climbed by 0.41% to $14.1 million in 2026.
• The last three Total Liabilities figures came in at $14.1 million (Q1 2026), $14.0 million (Q4 2025), and $12.6 million (Q3 2025), per Business Quant data.